NOT FOR DISTRIBUTION
Header cover image

Market Cap

€794.0m

Last Updated

2021/04/14 21:36 UTC

Data Sources

Company Financials +

Executive Summary

Mercator Medical S.A., together with its subsidiaries, produces medical gloves and distributes medical disposables in Europe, Russia, and internationally. More Details


Snowflake Analysis

Flawless balance sheet and undervalued.

Share Price & News

How has Mercator Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MM2 is more volatile than 75% of German stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: Insufficient data to determine MM2's volatility change over the past year.


Market Performance


7 Day Return

-1.3%

MM2

2.9%

DE Medical Equipment

0.2%

DE Market


1 Year Return

n/a

MM2

41.5%

DE Medical Equipment

42.4%

DE Market

Return vs Industry: Insufficient data to determine how MM2 performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how MM2 performed against the German Market.


Shareholder returns

MM2IndustryMarket
7 Day-1.3%2.9%0.2%
30 Day-11.9%7.6%5.1%
90 Day-21.2%13.0%9.6%
1 Yearn/a43.2%41.5%47.0%42.4%
3 Yearn/a95.4%87.0%23.5%12.8%
5 Yearn/a338.7%322.5%51.0%29.5%

Long-Term Price Volatility Vs. Market

How volatile is Mercator Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Mercator Medical undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: MM2 (€75.84) is trading below our estimate of fair value (€2678.51)

Significantly Below Fair Value: MM2 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: MM2 is good value based on its PE Ratio (4.1x) compared to the DE Medical Equipment industry average (46.3x).

PE vs Market: MM2 is good value based on its PE Ratio (4.1x) compared to the German market (28.2x).


Price to Earnings Growth Ratio

PEG Ratio: MM2's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: MM2 is good value based on its PB Ratio (3.6x) compared to the DE Medical Equipment industry average (7.9x).


Future Growth

How is Mercator Medical forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

-28.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MM2's earnings are forecast to decline over the next 3 years (-28% per year).

Earnings vs Market: MM2's earnings are forecast to decline over the next 3 years (-28% per year).

High Growth Earnings: MM2's earnings are forecast to decline over the next 3 years.

Revenue vs Market: MM2's revenue is expected to decline over the next 3 years (-8.8% per year).

High Growth Revenue: MM2's revenue is forecast to decline over the next 3 years (-8.8% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if MM2's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Mercator Medical performed over the past 5 years?

92.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MM2 has a high level of non-cash earnings.

Growing Profit Margin: MM2 became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: MM2's earnings have grown significantly by 92% per year over the past 5 years.

Accelerating Growth: MM2 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: MM2 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (44.3%).


Return on Equity

High ROE: MM2's Return on Equity (89.7%) is considered outstanding.


Financial Health

How is Mercator Medical's financial position?


Financial Position Analysis

Short Term Liabilities: MM2's short term assets (PLN1.1B) exceed its short term liabilities (PLN239.9M).

Long Term Liabilities: MM2's short term assets (PLN1.1B) exceed its long term liabilities (PLN6.3M).


Debt to Equity History and Analysis

Debt Level: MM2's debt to equity ratio (0.07%) is considered satisfactory.

Reducing Debt: MM2's debt to equity ratio has reduced from 62.6% to 0.07% over the past 5 years.

Debt Coverage: MM2's debt is well covered by operating cash flow (103858.5%).

Interest Coverage: MM2's interest payments on its debt are well covered by EBIT (325.4x coverage).


Balance Sheet


Dividend

What is Mercator Medical current dividend yield, its reliability and sustainability?

0.14%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: MM2's dividend (0.14%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.06%).

High Dividend: MM2's dividend (0.14%) is low compared to the top 25% of dividend payers in the German market (3.21%).


Stability and Growth of Payments

Stable Dividend: MM2 is not paying a notable dividend for the German market, therefore no need to check if payments are stable.

Growing Dividend: MM2 is not paying a notable dividend for the German market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: MM2 is not paying a notable dividend for the German market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MM2's dividend in 3 years as they are not forecast to pay a notable one for the German market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.3yrs

Average management tenure


CEO

Wieslaw Zyznowski (56 yo)

11.25yrs

Tenure

zł470,100

Compensation

Dr. Wieslaw Zyznowski has been the Chairman of Management Board at Mercator Medical Spólka Akcyjna since 2010. In the 90s Dr. Zyznowski co-founded the Mercator. From 1991 to 2001 he served as (apart from a...


CEO Compensation Analysis

Compensation vs Market: Wieslaw's total compensation ($USD123.50K) is below average for companies of similar size in the German market ($USD1.15M).

Compensation vs Earnings: Wieslaw's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: MM2's management team is considered experienced (2.3 years average tenure).


Board Members

Experienced Board: MM2's board of directors are considered experienced (7.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Mercator Medical S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Mercator Medical S.A.
  • Ticker: MM2
  • Exchange: BST
  • Founded: 1989
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: zł3.617b
  • Listing Market Cap: zł794.002m
  • Shares outstanding: 10.41m
  • Website: https://mercatormedical.eu

Number of Employees


Location

  • Mercator Medical S.A.
  • Heleny Modrzejewskiej 30
  • Kraków
  • 31-327
  • Poland

Listings


Biography

Mercator Medical S.A., together with its subsidiaries, produces medical gloves and distributes medical disposables in Europe, Russia, and internationally. The company offers surgical gloves for conducting ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/04/14 21:36
End of Day Share Price2021/04/14 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.